Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a joke! Well i guess we might actually get some really cheap shares
Bad news over there. CEO and directors selling their shares at half current pps. NOT GOOD.
I guess the News are out. Not good for shareholders here. Ouchh!!!
Suspension of trading by IIROC - TPI
Date : 03/11/2015 @ 12:54PM
Source :PR Newswire (Canada)
Stock : T Bird Pharma (TPI)
Quote : 0.45 0.0 (0.00%) @ 2:00PM
Suspension of trading by IIROC - TPI
T Bird Pharma (TSXV:TPI)
Intraday Stock Chart
Today : Wednesday 11 March 2015
VANCOUVER , March 11, 2015 / CNW / - IIROC suspended trading of the following titles:
Société : T-BIRD PHARMA INC
Symbol of the TSX Venture Exchange: TPI
Reason: At the Request of the Company Pending News
Halt Time (ET): 12 h 46
IIROC can make a decision to suspend (or stop) temporarily operations in respect of a security of a publicly listed company. Stops operations are implemented to ensure the proper functioning of a fair market.
IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on all markets equity and debt markets in Canada .
SOURCE Organization of Canada Trade Regulations (IIROC) - Halts / Reversals
Copyright 2015 Canada NewsWire
Looks like things are finally looking up. Would be nice if they formed a strong alliance with a Large Well Capitalized Partner. Hopefully this will be done shortly. GLTA
Looks like earnings will be released on Oct 14th sometime, not specified.
TPI Short Interest History & Short Sale Volume.
Short Interest History (%)
http://www.gurufocus.com/ShortInterest/TPI
Daily Short Sale Volume
http://www.shortvolume.com/
Avoid shorting please read and act!
http://www.contracts-for-difference.com/Borrowing-lending-shares.html
Wtf you talking about this is a Canadian company listed on thr TSX-V that news is not from this company..
TPI Technical Analysis
http://www.mediafire.com/convkey/6535/0eb86md22l9487gfg.jpg
1.Classic Breakout Setup (Pattern). $0.75
2.Cup and Handle Pattern.
IMO: Strong Buy
TPI News!
JCM Applies for Azithromycin API Import Certificate at India.
http://finance.yahoo.com/news/jcm-applies-azithromycin-api-import-130000919.html
Probably got their facility approval is my guess. Earnings Report due this month. That's about all that I can imagine. Short term earnings will be hurt but long term looks promising IMO.
Whats up with this one? Been on a tear the last few days.
In Yahoo Finance, TPI has eliminated the Messages, any opinion? Moe
That's been the case for quite a while. I have no idea why.
What is interesting is the MarketWatch news blurbs that get attached to the Fidelity Platform for TPI are for a Waste Management company with a similar ticker from Australia. Given the way most micro caps react to news it's prolly helping.
In Yahoo Finance, TPI has eliminated the Messages, any opinion? Moe
IMO: Strong Buy
Tianyin Pharmaceutical Co., Inc.
NYSE [AMEX]: TPI
http://www.mediafire.com/convkey/ff29/47qusq7iqhop0fefg.jpg
http://www.mediafire.com/convkey/87a3/h2a5ybzb496tmvtfg.jpg
+ Good Balance Sheet.
+ $0.40 - $0.60 => in Daily, Weekly Charts => Support Zone.
+ Insider Transactions => Insider Purchases, in the Open Market.
+ Good News.
+ Rumors => Buyback of shares.
IMO: Strong Buy
See TPI 4/22 Company Presentation at their website under Investor Relations. Revenue estimates for new orders.
Can you clarify please.
That News is HUGE. It means TPI can possibly generate USD outside China, and perhaps reinstate a dividend. Not to mention earnings potential.
IMHO
Shorts better watch out with today's announcement.
http://shortsqueeze.com/?symbol=TPI&submit=Short+Quote%99
The above message is my personal opinion and not to be construed as a recommendation to buy or sell this security. You should rely on your
own due-diligence when making investment decisions
Last Pattern:BULLISH ONE WHITE SOLDIER
2:17 am Tianyin Pharma: JCM updates on Azithromycin API Export (TPI) : Co provides update regarding the recent progress of the Jiangchuan Macrolide Facility. JCM has developed a new line of Azithromycin API products that support steady monthly export orders to South Asia.
Following a series of tests on quality, purity, intermediates contents, stereochemistry, stability in comparison with the international standards of Azi API, JCM has received monthly orders for manufacturing one of the major intermediates of Azi, Azithromycin amine at a competitive international price which varies from month to month according to the market demands and the foreign exchange rate. The monthly orders starting April this year for Azi Amine were estimated at 5-8 tons per month. TPI will provide updates on the development of the Azi Amine export on a quarterly base.
Gearing up for a push through 1.45. It's built a great base.
Better volume, chart looks good, insider purchases, balance sheet.
All point to a winner in this one IMO.
IMO Just a matter of time where it will break thru 1.45 and then up up and away
Looks like it is being accumulated again. Chart beginning to look good. http://americanbulls.com/SignalPage.aspx?lang=en&Ticker=TPI
We need to get this board going again. This is a great company!
It doesn't deserve to be selling so cheap! The worst is over with the Chinese Small Cap Pharmaceutical Sector. This is going to be one of the solid performers in the future. Good balance sheet, cash and earnings, good pipeline, good institutional following plus book value much higher than the stock price.
volume has gone up 100,000 very quickly and I think it is going to shoot up ever more dramatically although the stock may take a bit to see a peek I think good things are going to happen very soon!
Stock looks like it is still being accumulated. Good volume every day. Chart looks good. Might really getting ready for a breakout to new highs. IMO
Earnings announced. Nothing new. Still looks like stock under accumulation. See you next quarter.
Earnings announced. Nothing new. Still looks like stock under accumulation. See you next quarter.
70,000 shs insider buying. Stock is going up.
Earnings to be released 2/14/2014 Time to get in.
Earning to be announced on 2/14/2014
Take a look at the pe multiple on these drug stocks. Got to believe TPI will have a great 2014. I think that it is listed on the wrong exchange.
http://finance.yahoo.com/news/china-says-strengthen-supervision-ipos-164433010.html
Good technical bounce today. Stock looks cheap. Shares keep being accumulated under 90 cents per share.
Obvious earnings leak imo. Stock is running a day before earnings on above average volume. Shall be interesting to say the least. Hang on with the volume today may go ballistic.
Seeking alpha article says it's under valued and should be at 5.00 pps because of the revenues and earnings per share
Tianyin Pharma construction of QLF has been completed in mid April as previously projected (TPI) 0.58 0.00 : The Company targets mid June 2013 for the GMP certification process initiation for the QLF TCM pre-extraction facility.
Tianyin Pharmaceutical's CFO Discusses F2Q 2013 Results - Earnings Call Transcript
http://seekingalpha.com/article/1184881-tianyin-pharmaceutical-s-cfo-discusses-f2q-2013-results-earnings-call-transcript?source=yahoo
Total Cash (mrq): 37.54M
Total Cash Per Share (mrq): 1.28
Total Debt (mrq): 6.02M
Total Debt/Equity (mrq): 6.62
Current Ratio (mrq): 4.64
Book Value Per Share (mrq): 3.09
TPI Reports Fiscal Year 2012 Financial Results
PR NewswirePress Release: Tianyin Pharmaceutical Co., Inc.
CHENGDU, China, Sept. 28, 2012 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012.
Fiscal Year 2012 Ended June 30, 2012 Financial Highlights:
FY2012 revenue delivered $69.6 million compared with $95.2 million in FY2011,
Operating income delivered $8.5 million, compared with $18.1 million in FY2011,
Net Income was $6.4 million compared with $15.7 million in FY2011,
Earnings per share of $0.22 per basic share, and $0.22 per diluted share, compared with $0.55 per basic share, or $0.53 per diluted share in FY2011,
Cash and cash equivalents totaled $35.2 million on June 30, 2012; Operating cash flow for the fiscal year ended June 30, 2012 was $8.0 million, compared with $14.2 million for the fiscal year ended June 30, 2011.
Comparison of results for the fiscal years ended June 30, 2012 and 2011:
* Net income includes a $1.6 million non-cash gain due to the change in the fair value of our warrants liability.
Sales for the fiscal year ended June 30, 2012 was $69.6 million, decreased 26.9% from $95.2 million for the fiscal year ended June 30, 2011, due to generic pricing pressure under the ongoing healthcare reform. We witnessed a 17% reduction of TPI's organic portfolio revenue from $63.9 million for the fiscal year 2011 to $53.0 million for the fiscal year 2012. Our core five products by sales are: Ginkgo Mihuan Oral Liquid (GMOL): $17.1 million; Apu Shuangxin Granules (APU) $2.7 million; Xuelian Chongcao (XLCC): $2.2 million; Azithromycin Dispersible Tablets (AZI): $3.0 million; Qingre Jiedu Oral Liquid (QRE): $3.5 million. The core product portfolio totaled $28.5 million or 53.8% of the organic portfolio revenue.
http://finance.yahoo.com/news/tpi-reports-fiscal-2012-financial-093600981.html
I owned TPI back in 2009-2011. They canceled the dividend because they felt the money was better used to expand production.
Been doing a little more early DD. Looks like TPI is AMEX listed. With price so low for so long, are they in danger of losing the listing, any news on this yet? Deadlines? R/S possibly coming?...
Also I see they had a dividend in 2009-10. Any idea why they stopped the dividend? Might they restore it to boost the price back up over $1 and save the Amex listing?
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
132
|
Created
|
09/25/08
|
Type
|
Free
|
Moderators |
http://finance.yahoo.com/q/ks?s=TPI
Tianyin Pharmaceutical Co., Inc. engages in the development, manufacture, marketing, and sale of modernized traditional Chinese medicines and other pharmaceuticals in the People?s Republic of China. The company?s products are intended to address various medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology, and pediatrics. It manufactures a portfolio of 39 modernized traditional Chinese medicines and pharmaceuticals, and has a pipeline of 17 products, which are pending regulatory approvals with the China State Food and Drug Administration. The company was founded in 1994 and is based in Chengdu, the People?s Republic of China.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |